UBS’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$250K Buy
7,700
+800
+12% +$27.2K ﹤0.01% 4966
2014
Q2
$241K Sell
6,900
-600
-8% -$19.7K ﹤0.01% 4952
2014
Q1
$238K Sell
7,500
-7,000
-48% -$195K ﹤0.01% 5005
2013
Q4
$367K Buy
14,500
+1,700
+13% +$40.7K ﹤0.01% 4642
2013
Q3
$274K Buy
12,800
+3,400
+36% +$69.8K ﹤0.01% 4803
2013
Q2
$182K Buy
+9,400
New +$205K ﹤0.01% 5196

Other funds holding PTEN

UBS's PTEN Position: Q3 2014 in Review

UBS reduced its Patterson-UTI (PTEN) stake by 38% in Q3 2014, selling an estimated $5.98M and leaving 286,823 shares worth $9.33M. The position accounts for 0.01% of the portfolio, ranked #1508.

UBS first reported a position in PTEN in Q2 2013 and has held it in 6 quarters since. The position peaked at $16.2M in Q2 2014. 329 funds tracked by Wall St. Rank hold PTEN as of Q3 2014.

  • UBS held 286,823 shares of Patterson-UTI worth $9.33M as of Q3 2014.
  • UBS sold 176,039 Patterson-UTI shares in Q3 2014, an estimated $5.98M.
  • Patterson-UTI made up 0.01% of UBS's portfolio in Q3 2014, its #1508 holding.
  • UBS first reported a position in Patterson-UTI in Q2 2013 and has held it in 6 quarters since.
  • UBS's Patterson-UTI position peaked at $16.2M in Q2 2014.
  • 329 funds tracked by Wall St. Rank held Patterson-UTI as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.